| 1418 |
Molecular Mechanism of Multi-drug Resistance in Mycobacterium tuberculosis |
16/06/2024 |
Laboratory services and management |
| 1424 |
Flow Chart of M/XDR-TB Patients on Longer Oral Regimen from Diagnosis to Treatment Outcome |
16/06/2024 |
Laboratory services and management |
| 1426 |
Key Points of Health Education and Counselling in DR-TB Care |
16/06/2024 |
Laboratory services and management |
| 1550 |
Management of DR-TB ADR: Metallic Taste |
16/06/2024 |
Laboratory services and management |
| 1556 |
Understanding Key elements of Molecular Biology |
16/06/2024 |
Laboratory services and management |
| 1558 |
Structure of DNA in a Prokaryotic Cell |
16/06/2024 |
Laboratory services and management |
| 1561 |
Molecular Basis of Genetic Code and Mutation |
16/06/2024 |
Laboratory services and management |
| 1566 |
Explanation of Treatment of Non-tuberculous Mycobacteria [NTM] |
16/06/2024 |
Laboratory services and management |
| 1570 |
Use of Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen in Patients with Renal Impairment |
16/06/2024 |
Laboratory services and management |
| 1705 |
TB Laboratory Design and Facilities as a Biosafety Measure |
16/06/2024 |
Laboratory services and management |
| 1707 |
Ventilation in TB Laboratories as a Biosafety Measure |
16/06/2024 |
Laboratory services and management |
| 1710 |
Low-risk TB Laboratories |
16/06/2024 |
Laboratory services and management |
| 1711 |
Emergency Preparedness Plan in TB Lab Settings |
16/06/2024 |
Laboratory services and management |
| 1712 |
TB Laboratory Accidents Leading to Infectious Spillage |
16/06/2024 |
Laboratory services and management |
| 1713 |
Fire Safety in TB Lab Settings |
16/06/2024 |
Laboratory services and management |
| 1724 |
Monitoring of Treatment by Smear and Culture |
16/06/2024 |
Laboratory services and management |
| 1726 |
MGIT 960 Instrument: Operation |
16/06/2024 |
Laboratory services and management |
| 1084 |
Recording and Reporting at Ayushman Bharat Health and Wellness Centres |
16/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1632 |
Supervision by STS |
16/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1681 |
Internal Evaluation |
16/06/2024 |
Surveillance, SM&E and Epidemiology |
| 869 |
Incentive For Notification and Outcome Declaration |
16/06/2024 |
Ni-kshay, Information Systems and DBT |
| 1348 |
Paper-based Format: Stock Register |
16/06/2024 |
Ni-kshay, Information Systems and DBT |
| 1081 |
Functions of District National Health Mission |
16/06/2024 |
NTEP PIP |
| 862 |
PPSA |
16/06/2024 |
Partnerships and Multisectoral Engagement |
| 1191 |
Types of Health Facilities in the Private Sector: Private Labs |
16/06/2024 |
Partnerships and Multisectoral Engagement |
| 1603 |
Joint Effort for Elimination of Tuberculosis [JEET] Model of the Patient Provider Support Agency [PPSA] |
16/06/2024 |
Partnerships and Multisectoral Engagement |
| 1756 |
How to reach out to TB patients in the private sector |
16/06/2024 |
Partnerships and Multisectoral Engagement |
| 846 |
Reconstitution of drugs like second line, newer, TPT etc |
16/06/2024 |
Procurement and supply chain management |
| 850 |
Stock register for Drugs |
16/06/2024 |
Procurement and supply chain management |
| 1185 |
NTEP State Drug Store [SDS] Structure and Functions |
16/06/2024 |
Procurement and supply chain management |
